Nexentis Technologies (NXTS) Return on Equity [ROE] (2021 - 2026)
Nexentis Technologies' Return on Equity [ROE] came in at -156.95% for Q2 2026, up 48.26 percentage points from -205.21% a year earlier.
Powered by 
Analysis
Nexentis Technologies (NXTS) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Nexentis Technologies' Return on Equity [ROE] was -40.38%, up 56.56 percentage points from FY2024.
- Return on Equity [ROE] carries a four-year change of +123.24 percentage points (FY2021 to FY2025).
- Going back by year, Return on Equity [ROE] was -96.94% in FY2024 (+22.12 pp), -119.07% in FY2023 (-23.92 pp), -95.14% in FY2022 (+68.48 pp) and -163.62% in FY2021.
- The five-year range for quarterly Return on Equity [ROE] is -205.21% (Q2 2025) to -33.33% (Q4 2025).
- Year-over-year, Return on Equity [ROE] increased in five of the last seven quarters, with an average year-over-year change of +8.29 percentage points.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q4 2025 (a gain of 74.97 percentage points), and the weakest in Q2 2025 (a drop of 93.95 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Nexentis Technologies | 1.18 Mn | -21.59 Mn | - | -156.95% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -156.95% |
| Dec 31, 2025 | -33.33% |
| Sep 30, 2025 | -94.00% |
| Jun 30, 2025 | -205.21% |
| Mar 31, 2025 | -139.81% |
| Dec 31, 2024 | -108.29% |
| Sep 30, 2024 | -102.31% |
| Jun 30, 2024 | -111.26% |
| Mar 31, 2024 | -104.63% |
| Dec 31, 2023 | -131.10% |
| Sep 30, 2023 | -135.15% |
| Jun 30, 2023 | -108.59% |
| Mar 31, 2023 | -117.23% |
| Dec 31, 2022 | -90.64% |
| Sep 30, 2022 | -104.21% |
| Jun 30, 2022 | -112.24% |
| Mar 31, 2022 | -96.98% |
| Dec 31, 2021 | -68.34% |
| Sep 30, 2021 | -41.98% |
| Jun 30, 2021 | -65.94% |
API Access
Nexentis Technologies Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NXTS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "NXTS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NXTS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();